ESC Premium Access

Validation of the CARPREG II risk stratification model and the WHOm scale in pregnant women with heart disease

Congress Presentation

About the speaker

Miss Diana Botero

University of Antioquia, Medellin (Colombia)
0 follower

187 more presentations in this session

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation

Speaker: Doctor C. Su (Taichung, TW)

Thumbnail

Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study

Speaker: Doctor T. Rhee (Seoul, KR)

Thumbnail

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

Speaker: Professor W. Shimizu (Tokyo, JP)

Thumbnail

The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.

Speaker: Doctor S. Alampoondi Venkataramanan (Worcester, US)

Thumbnail

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Miss D. Botero, Professor J. McMurray, Doctor C. Su, Doctor T. Rhee, Professor W. Shimizu...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Mode of intervention in aortic stenosis.

28 August 2021

Open Access

GUIDE-HF - Panel discussion.

27 August 2021

Open Access

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk